Radio Advisory

(This episode originally aired on February 10, 2026. Dr. Omar Lateef has since announced his intention to retire from Rush Health in June 2027.)

As financial pressure mounts and the healthcare safety net continues to strain, academic medical centers are drawing on their culture of innovation to pursue better outcomes — and narrow life expectancy gaps in the communities they serve.

In this episode of Radio Advisory, host Rae Woods sits down with leaders from Rush University Medical Center to explore how health systems can stay focused on results amid tightening margins, political scrutiny, and ongoing uncertainty in grant fu...

(This episode originally aired on February 3, 2026. Stay tuned towards the end of the conversation for an update on the state of pediatric hospitals midway through 2026.)

Pediatric hospitals are one of the most important segments in the industry to watch right now. Although children’s hospitals make up only 5% of total hospital market share, more than 40% of U.S. children rely on Medicaid, leaving pediatric organizations disproportionately exposed as the Medicaid-related provisions of the One Big Beautiful Bill Act take effect.

The pressures inside pediatric care were mounting even before this moment. After years of outperforming ad...

(This episode originally aired on March 17, 2026.)

As health systems pursue growth beyond traditional avenues, the role of the strategic planner is becoming increasingly complex. High level directional data is no longer enough — achieving meaningful, differentiated growth now requires leveraging granular, sophisticated data to inform investment decisions.

In this episode, host Rachel Woods sits down with Advisory Board experts Sebastian Beckman and Ellie Wiles to explore how health systems can rethink strategic planning for 2026 and beyond. Together, they unpack what it should actually look like to democratize data, why data governance matters just as much as da...

For years, regional health plans benefited from powerful tailwinds: Medicare Advantage growth, Medicaid expansion, and a prospering ACA marketplace. But many of those growth engines have stalled, just as new pressures emerged: rising utilization, runaway spend, pricing uncertainty and more scrutiny from patients and policy makers. The result is a dramatically different financial reality for health plans. In 2024, only eight of 33 Blues plans reported positive operating margins.

In this episode, host Rae Woods sits down with Jared Landis, Vice President of Advisory Board's Health Plan Research practice, to unpack how regional plans got here and the three-year...

In this episode, Abby Burns welcomes back Megan Zweig, CEO of Rock Health Advisory, to answer audience questions submitted during Advisory Board's Research Summit in Carlsbad, California.

Together, they explore how health systems are engaging with the explosion in consumer-generated data, the role of medtech and pharma in AI-enabled innovation, and why AI enablement may be able to unlock personalized care for a wider range of patients.

We’re here to help:

Oncology is simultaneously one of healthcare's greatest success stories and one of its biggest financial challenges. Cancer care continues to benefit from breakthroughs in precision medicine and early detection, even as oncology spending is projected to approach $200 billion by 2029. At the same time, cancer programs are facing rising patient volumes, growing demand for advanced therapies, and mounting pressure to improve access and affordability.

In this episode, hosts Abby Burns and Chloe Bakst welcome oncology expert Gaby Marmolejos to break down the trends shaping cancer care in 2026 and beyond. Together, they explore improvements in community-based access to advanced...

Value-based care is entering its accountability era. Participation in value-based arrangements continues to grow, even as financial pressures weigh down on both providers and payers. But CMMI is setting a clear tone about what it expects from stakeholders moving forward: results.

Host Abby Burns sits down with Advisory Board experts Clare Wirth, Payton Grimes, and Rhea Jain to explore what’s changed — and what hasn’t — in value-based care. From Medicare Advantage turbulence to the push for specialist engagement and greater downside risk, the group breaks down what leaders need to know about how the value-based care landscap...

After years of uncertainty, many healthcare executives say they’ve experienced more change in the past five years than in their entire careers. Policy shifts, evolving patient expectations, and rapid advances in AI are all colliding at once — forcing leaders to rethink how they operate and where they invest.

But here’s the surprising part: the overwhelming sentiment isn’t panic. It’s clarity.

In this episode, host Rachel (Rae) Woods sits down with Advisory Board researchers Morghen Philippi and Marisa Nives to share what they’re hearing from months of research conversations with leaders across the e...

Digital health funding is heating up—but where are the dollars going? And what does it mean for health systems’ digital health strategies?

In this live episode, recorded at Advisory Board’s Research Summit, host Abby Burns sits down with Megan Zweig, President and CEO of Rock Health Advisory, for an update on what’s going on in the world of digital health funding. Together, they unpack what investment activity looks like and explore questions around what constitutes an investable thesis in 2026, how health systems are—or could be—engaging in the startup ecosystem, and what it takes to be...

As health systems anticipate greater downward pressures on margins in the months and years to come, they’re homing their growth strategies accordingly. As we’ve been saying in our research the past couple of years, “sustainability” is now the name of the game. Here’s the conundrum: our research also shows that 90% of systems are betting on the same growth plays as their competition. And more and more, those bets converge on a common goal: win more commercial volumes.

In this episode, host Abby Burns sits down with Advisory Board experts Shay Pratt and Emily Heuser to unpack...

CMS continues to pull on the levers it has at its disposal to rein in national healthcare spend, including rulemaking around Medicare Advantage. In April, CMS announced the final rate for MA plans for CY2027, after a controversial proposed rule generated animated pushback — and a fair bit of panic — among payers.

In this episode, host Abby Burns speaks with Alex Balmes, Vice President of Actuarial Services at Optum, to unpack what did — and didn’t — end up in the final rate announcement, and what that signals for the future of the Medicare Advantage program. Together, they explore the compon...

Maternity care touches nearly every corner of the U.S. health system. About 25% of all hospitalizations involve a mother or newborn, and maternity spending accounts for roughly 0.8% of U.S. GDP — making it one of the most economically significant service lines in health care. Against that backdrop, a little noticed decision to unbundle maternity billing codes represents a generational shift in how pregnancy, delivery, and postpartum care are paid for.

In this episode of Radio Advisory, host Rae Woods sits down with Neel Shah, MD, Chief Medical Officer at Maven Clinic, to break down what the new ma...

Health care leaders are navigating one of the most volatile policy environments in decades. The next major reform fight hasn’t arrived yet — but in its place, a steady wave of rulemaking, regulatory shifts, and enforcement actions is driving real change. Policies are evolving faster, reversing more often, and creating a level of uncertainty that makes even the most seasoned strategists question what to act on, what to wait out, and what to ignore.

This moment of policy whiplash isn’t theoretical — it’s reshaping care delivery models, workforce strategy, and long term investment decisions across the industry.<...

After a decidedly difficult few years in the world of nursing, things have seemingly gotten better — at least, on paper. And that’s reflective of a lot of hard work on the part of nursing leaders. But when we look at how long nurses plan to stay in the profession, we see a different story taking shape.

In this episode of Radio Advisory, host Abby Burns is joined by Advisory Board nursing expert Ali Knight and Optum expert Sherilynn Quist. Together, they unpack what today’s workforce data is really telling us and what it misses, the root c...

Across the industry, leaders are talking about a “battle of the bots”—with payers and providers racing to deploy AI across the revenue cycle. But that narrative may be more hype than reality.

In this episode, Rae Woods is joined by Advisory Board experts Isis Monteiro and Elysia Culver to separate fact from fiction. They break down where AI is actually delivering value today—and why it’s showing up as efficiency gains and cost avoidance, not revenue growth.

And they make the case for a different approach: stop chasing AI for its own sake, and start...

After more than a decade of effort, healthcare still struggles with the same consumer pain points: affordability, access, and trust. Despite investments in price transparency, virtual care, and navigation tools, the patient experience remains fragmented, leaving leaders to wonder whether healthcare consumerism ever truly delivered on its promise.

In this episode, host Rae Woods invites Advisory Board experts Devin Airey, Shay Pratt, and Natalie Trebes to take a candid look at why the consumer revolution stalled, what consumerism tactics healthcare leaders need to let go of, and where the industry should double down heading into the next...

What has price transparency data taught us about healthcare prices? Price transparency laws were originally put in place to make it possible for patients to act like consumers. We’re not there yet. But as federal requirements and enforcement tighten, health plans and providers are sharing more and better data, giving us a clearer picture of the price of care across services, organizations, and markets.

In this episode, host Abby Burns sits down with CEO of Revelar Analytics, Maria Nikol, to better understand how and why leaders across the industry should leverage price transparency data to help th...

The U.S. healthcare system is approaching a major inflection point. Nearly $1 trillion in Medicaid cuts are set to take effect in January 2027, driven by new work requirements, more frequent eligibility checks, and tighter limits on state financing.

While the policy changes are months away, their consequences are already clear: millions of Americans are at risk of losing coverage, and provider organizations — many operating on margins near zero — will absorb the downstream impact through rising uncompensated care.

In this episode, hosts Rae Woods and Abby Burns are joined by former Optum Executive Director of Product and...

In this bonus episode of Radio Advisory, managing producer Chris Phelps and host and executive producer Rae Woods compare notes from the 2026 ViVE digital health conference. They break down what stood out on the main stage and the show floor—from where AI is over and under hyped, to why point solutions keep falling short, to what it actually takes to scale technology in healthcare. They also surface the big questions they still have about the healthcare industry’s digital future.

We’re here to help:

Payers are operating at the center of converging pressures: rising costs, accelerating utilization, heightened public scrutiny, and a wave of CMS reforms that are reshaping expectations around transparency, interoperability, prior authorization, and accountability. Medicare Advantage has become the front line for these shifts—exposing tensions between regulatory oversight, margin compression, and growing demands for better member and provider experiences.

Against this backdrop, health plans are being asked to do more with less—while proving real value through measurable outcomes, trust, and access.

In this episode, recorded in February at the ViVE digital health and healthcare inno...

Academic medical centers (AMCs) sit at the heart of U.S. healthcare, driving scientific discovery, providing crucial clinical care, and training the next generation of clinicians. They also face mounting financial pressures and a shifting policy landscape that threatens their ability to sustainably deliver on this tripartite mission. And their complex structures make rapid business model transformation tough — at a time when it has become essential for survival.

In this episode, host Abby Burns invites Advisory Board expert Wes Campbell to provide an update on how AMCs are doing amidst the current climate, unpack how and why po...

Employer-sponsored insurance is reaching a tipping point. What was once a predictable 2–4% annual increase in employer health spending has given way to double digit growth, driven by surging drug costs, rising utilization across all age groups, and escalating provider rates. For many employers—especially smaller organizations with less margin for error—absorbing these costs is no longer viable. As economic conditions shift and the labor market cools, the balance of power between employers and employees is changing, opening the door to more aggressive cost-control strategies.

In this episode, host Rachel (Rae) Woods is joined by Advisory Board expert...

For life sciences companies, access and adoption of clinical products is no longer as simple as demonstrating strong outcomes at a fair price. As payers and providers face mounting financial pressure and operational complexity, they are scrutinizing their partners more closely — expecting clearer evidence, more relevant value narratives, and support that reflects real world constraints.

In this episode, host Rachel (Rae) Woods sits down with Advisory Board experts Gina Lohr and Nick Hula to unpack how med tech and pharma companies should adapt their product and partnership strategies. Together, they explore why a single value story no lo...

As health systems pursue growth beyond traditional avenues, the role of the strategic planner is becoming increasingly complex. High level directional data is no longer enough — achieving meaningful, differentiated growth now requires leveraging granular, sophisticated data to inform investment decisions.

In this episode, host Rachel Woods sits down with Advisory Board experts Sebastian Beckman and Ellie Wiles to explore how health systems can rethink strategic planning for 2026 and beyond. Together, they unpack what it should actually look like to democratize data, why data governance matters just as much as data access, and how service line leaders can pa...

How did health systems perform in 2025, and which strategic growth priorities are top-of-mind for 2026?

Health systems have entered the year with both momentum from buoyed volumes, and mounting pressure as those volumes don’t necessarily translate to healthy margin.

This week, host Abby Burns sits down with Advisory Board expert Marisa Nives and Optum consulting expert Alex Kist to unpack results from Advisory Board’s annual Strategic Planner Survey. They explore how health systems are—and aren’t—running at growth, and what separates the systems that are able to turn volumes and revenue into margin, fr...

After a turbulent 2025, the early months of 2026 are proving that the policy landscape isn’t quieting down. Federal agencies are rolling out new payment models, lawmakers are revisiting long debated rules, and courts continue to shape what policies move forward and which stall. From value based payment to drug pricing and site of care policy, leaders are navigating a fast shifting environment with real implications for finances, operations, and long term strategy.

In this episode, host Abby Burns invites three Advisory Board experts to break down the major policy forces that leaders need to watch now:

Infusion services make up a roughly $150 billion market in the U.S., and underpin the financial stability of major service lines, especially oncology. Historically, health systems have enjoyed strong volumes, favorable reimbursement, and access to 340B discounts that keep their infusion business profitable. But rising competition, payer and employer driven site of care shifts, and looming policy changes are putting pressure on what many leaders have relied on as a stable, margin accretive business.

In this episode, host Abby Burns sits down with Advisory Board expert Chloe Bakst to break down what’s actually happening in the in...

Once a high growth, high margin line of business for health plans, Medicare Advantage (MA) is now in the middle of a financial reset.

Growth has slowed, margins have turned negative, and federal financial support is eroding — with CMS proposing a near flat reimbursement increase for 2027. As a result, plans are exiting markets, tightening benefit designs, and shifting their focus toward Special Needs Plans (SNPs). At the same time, seniors are facing rising costs, fewer perks, and more frequent plan changes.

To cut through the noise and understand what’s really happening beneath the headlines, host...

As financial pressure mounts and the healthcare safety net continues to strain, academic medical centers are drawing on their culture of innovation to pursue better outcomes — and narrow life expectancy gaps in the communities they serve.

In this episode of Radio Advisory, host Rae Woods sits down with leaders from Rush University Medical Center to explore how health systems can stay focused on results amid tightening margins, political scrutiny, and ongoing uncertainty in grant funding.

Dr. Omar Lateef, President and CEO of Rush, and Dr. David Ansell, Senior Vice President for Community Health Equity, describe ho...

Pediatric hospitals are one of the most important segments in the industry to watch right now. Although children’s hospitals make up only 5% of total hospital market share, more than 40% of U.S. children rely on Medicaid, leaving pediatric organizations disproportionately exposed as the Medicaid-related provisions of the One Big Beautiful Bill Act take effect.

The pressures inside pediatric care were mounting even before this moment. After years of outperforming adult hospitals, children’s hospitals have seen margins fall from double digits to just 1% last year. Rising bad debt, higher supply and labor costs, a rapid shift towa...

GLP-1s have quickly become a cornerstone of obesity and metabolic care — but the real challenge isn’t whether they work, it’s how the healthcare system uses them. Leaders are grappling with tough questions around hype, access, safety, cost, and long-term sustainability.

In this episode, recorded live at the 2025 HLTH conference, Rae Woods moderates a candid conversation with four physician leaders:

In Part 1 of Radio Advisory’s What CEOs need to know in 2026 series, we explored how responsibility for protecting access is diffusing as the safety net continues to fray. But that’s only one way control over healthcare delivery is shifting. In Part 2, we turn to other subtle — but significant — ways power is moving away from traditional centers of influence.

As utilization and costs rise, purchasers are reaching the limits of their traditional approaches to spend management. In 2026, new players are stepping in as purchasers seek specialized solutions for specific treatments and conditions, increasingly delegating outcomes management to third...

In 2026, traditional healthcare leaders are facing nontraditional power dynamics. That’s why we’re kicking off the new year with a two-part series focused on the trends and challenges CEOs must be prepared to navigate in the year ahead.

In Part 1, hosts Rachel (Rae) Woods and Abby Burns sit down with Advisory Board experts Natalie Trebes and Max Hakanson to unpack how the shrinking safety net is reshaping access to care – and why every CEO needs to prepare for the ripple effects.

Coming next week: In part two of our What CEOs Need to Kno...

In 2026, Radio Advisory is diving into the biggest questions shaping the future of healthcare. We aren’t just here to talk about challenges, we’re here to help you determine your next best action. Our first episode of the year drops Tuesday, January 13. Subscribe wherever you get your podcasts.

We want to hear from you. What do you want to hear about in 2026? Where are you seeing opportunities or facing challenges you think we should explore? Email us at podcasts@advisory.com

We’re here to help:

Advisory Board is here to do two things: tackle the toughest questions keeping healthcare leaders up at night, and push leaders' thinking on the questions they aren’t asking – but should be. In 2025, we navigated a landscape of major shifts, from policy changes, the growing presence of AI, drug innovations, and more. As we head into 2026, we are keeping that momentum going to deliver the insights you need to stay ahead.

That’s why this week, hosts Rachel (Rae) Woods and Abby Burns pass the microphone to six Advisory Board researchers to preview their top questions and topics...

The national spotlight on food and chronic disease management is intensifying, especially given the momentum of the “Make America Healthy Again” movement. This presents an opportunity to finally move the needle on incorporating healthy food and nutrition into care delivery — but our traditional healthcare system is not set up to do this well, or at scale. Healthcare leaders need to learn from the experts who have been doing this work successfully in their communities.

That’s why this week, live from Advisory Board’s Nashville Summit, host Abby Burns speaks with Tomi Ogundimu, Chair of the Board of DC Gree...

In last week’s episode, Advisory Board experts explored why leaders have a responsibility to combat rising patient distrust. The challenge? Most providers aren’t prepared — and often haven’t been taught — how to respond effectively.

Distrust isn’t just about debunking misinformation. The combination of low-quality research and panic headlines has made it harder for both providers and patients to separate credible science from misinformation. But there are actionable strategies leaders can use to identify what fuels mistrust and effectively communicate with patients in ways that build confidence.

This week, host Rachel (Rae) Woods sits down wi...

Patient dissatisfaction with the healthcare system has long been a concern — but today, it’s something far more serious: outright distrust. Between 2023 and 2025, the share of Americans who don’t trust their doctor at all to make the right recommendations jumped by eight percentage points. Now, nearly one in six patients lack confidence in their physician.

Let’s be clear: patient distrust may not be the fault of health leaders — but it is absolutely their problem to solve. Rebuilding trust is a business imperative because distrust affects clinical quality, workforce stability, public health, and the financial health of organiz...

We’re in the midst of an AI gold rush. Every corner of healthcare is racing to harness generative AI for productivity and cost savings. But here’s the catch: healthcare isn’t Silicon Valley. The mantra of “move fast and break things” doesn’t work in a high-risk, complex environment. When it comes to AI in healthcare, safety and effectiveness must come before speed.

This week on Radio Advisory, guest host and Advisory Board digital health expert Ty Aderhold sits down with David Woods, Mike Rayo, and Dane Morey from the Cognitive Systems Engineering Lab at The Ohio Sta...

Nearly 16 million veterans live in the United States, and while 9 million receive care through the Veterans Health Administration, about 40% rely entirely on civilian healthcare. That’s where the challenge begins: many veterans are navigating a system that isn’t designed for their unique health needs.

Veterans outside the VA system often face barriers that lead to poorer outcomes—delays in diagnosis, fragmented care, and overlooked service-related conditions. The healthcare system must do better.

In this episode of Radio Advisory, host Rachel (Rae) Woods talks with Optum Serve experts Christi Kruse and Christine Erspamer about what it tak...